Unicorn status validates momentum as the only unified global payments network for today’s borderless, tokenized economy

SAN FRANCISCO, Jan. 27, 2026 — Mesh, the leading crypto payments network, today announced it closed a $75 million Series C funding round, bringing its total amount raised to over $200 million and valuing the company at $1B. Dragonfly Capital led the round, with participation from Paradigm, Moderne Ventures, Coinbase Ventures, SBI Investment, and Liberty City Ventures.

Crypto is making the payment rails built for an analog world obsolete, and Mesh is leading this movement by connecting a fragmented global crypto market and bypassing the slow settlements and excessive fees long established by traditional finance. As the industry moves from experimentation to real-world adoption, capital is increasingly flowing toward infrastructure rather than speculation, with Mesh standing out as the only unified payment network for a borderless, tokenized economy.

The round also accelerates Mesh’s expansion into regions like Latin America, Asia and Europe, fueling product development and strengthening a global network that already reaches more than 900 million users worldwide. Previously, the company announced its expansion into India, citing the country’s young, tech-savvy population and $125B+ in annual remittances as reasons for the move. Mesh also previously announced support for Ripple USD and forged new partnerships with Paxos and Rain.

“Crypto is crowded by design, with new tokens and new protocols emerging every day,” said Bam Azizi, Co-founder and CEO of Mesh. “That fragmentation creates real friction in the customer payment experience. We are focused on building the necessary infrastructure now to connect wallets, chains, and assets, allowing them to function as a unified network. This funding validates that the winners of the next decade won’t be those who issue the most tokens, but those who build the network of networks that makes traditional card rails obsolete.”

“Payments are entering a new era where value moves as software. Mesh is building the interoperability layer that makes crypto practical at scale: consumers can spend any asset, merchants can settle instantly in the stablecoin or fiat they want, and the complexity stays under the hood. That ‘any-to-any’ experience is exactly what mainstream adoption demands, and we’re excited to lead this round as Mesh becomes the universal network for global, compliant crypto payments,” said Rob Hadick, General Partner at Dragonfly.

Solving the “Stablecoin Paradox” Through Universal Interoperability

While the rapid growth of new stablecoins and blockchains signals a healthy industry, it’s also reintroducing fragmentation that crypto was designed to solve. In 2025, stablecoins reached a historic $300B market cap and processed over $27T in annual transaction volume.

This rapid growth has created isolated pockets of liquidity, however, forcing users to navigate a maze of disparate platforms and complex network choices. Mesh serves as the neutral layer that unifies this fragmented landscape, ensuring the future of payments is built on infrastructure that makes all assets universally spendable.

As the only network that works with all crypto, Mesh remains asset-agnostic, providing the infrastructure that allows the entire industry to function as a single system. Through its proprietary SmartFunding technology, Mesh enables a true “any-to-any” advantage: consumers pay with any asset they hold – from Bitcoin to Solana – while merchants receive instant settlement in their preferred stablecoin (e.g., USDC or PYUSD) or local currency (e.g., dollars or euros).

A portion of Mesh’s $75M Series C round was settled using stablecoins to demonstrate that this infrastructure is ready for high-stakes, real-world use. This milestone serves as definitive proof that global institutions are now comfortably relying on blockchain-native settlement when enterprise-grade execution, auditability, and controls are firmly in place.

For more information about Mesh, visit https://meshpay.com/.

About Mesh
Founded in 2020, Mesh is building the first global crypto payments network, connecting hundreds of exchanges, wallets, and financial services platforms to enable seamless digital asset payments and conversions. By unifying these platforms into a single network, Mesh is pioneering an open, connected, and secure ecosystem for digital finance. For more information, visit https://www.meshpay.com/. 

Contact: [email protected]

About Dragonfly Capital
Dragonfly is a $4B crypto-focused global investment firm. Since 2017, Dragonfly has been at the forefront of blockchain and crypto innovation with a long-term oriented, technical, and research-driven approach, having been early backers of some of the most influential protocols and companies in the industry.

Contact: [email protected]

SOURCE Mesh

With today’s launch, any finance team can begin using Concourse for free in minutes through a new open-access onboarding experience. Teams can immediately connect core data sources such as QuickBooks, Ramp, Stripe, or CSVs, without custom setup or long implementation cycles. Previously available only through limited access and supported by a multi-thousand company waitlist, Concourse is now bringing its enterprise-grade AI agents to teams of all sizes, with transparent, usage-based pricing.

“Finance teams have long been forced to choose between flexibility and automation,” said Matthieu Hafemeister, CEO and Co-Founder of Concourse. “Concourse eliminates that tradeoff by embedding AI agents directly into the financial stack. Our agents automate analysis using natural language, while showing their work, from logic to underlying queries, so teams can trust the answers and understand what’s driving the business.”

While traditional finance software relies on rigid, deterministic workflows, critical insights still live across spreadsheets and disconnected systems. As companies scale, this fragmentation creates manual work, slows decision-making, and limits finance teams’ ability to keep up with the pace of the business. Concourse addresses this by connecting AI agents directly to a company’s existing financial stack, including ERPs, billing systems, CRMs, expense tools, and data warehouses.

Customers using Concourse are able to move faster and operate with significantly greater capacity. Teams generate reports and presentation-ready outputs in minutes, automate recurring analysis through proactive reporting agents, and keep pace as the business grows. Finance teams report reducing manual work by up to 75%, freeing leaders to focus on higher-value analysis rather than data manipulation. Within months of adoption, teams typically produce multiple times more analysis than before, driving deeper insights and better decision-making.

“Concourse is the kind of company we like to fund with strong product-market fit, clear and growing demand,” said Dalton Caldwell, Co-Founder and Partner at Standard Capital. “Matthieu and Ted have already demonstrated how impactful these agents can be inside large organizations. We’re excited to support this next phase, where any finance team can start using Concourse immediately,” added Paul Buchheit, Co-Founder and Partner at Standard Capital.

Concourse agents are already deployed across finance teams at companies including Palo Alto Networks, Front, and Tecovas, spanning Fortune 500 enterprises, unicorns, and high-growth startups. With the platform now generally available, Concourse is extending the same capabilities trusted by large enterprises to finance teams of any size. The Series A funding will also support continued investment in agent capabilities for enterprise customers, while broadening access across the broader finance market.

Concourse includes a built-in transparency panel that surfaces each agent’s reasoning, including the underlying SQL and Python used to generate outputs. The platform is designed with enterprise-grade security and compliance, including SOC 2 Type II certification, encryption, SAML/SSO support, and strict data-handling controls. The new funding will further support investments in security, reliability, and agent development as Concourse continues to scale.

ABOUT CONCOURSE

Concourse builds AI agents for corporate finance teams. The platform works alongside finance teams to automate the most manual and time-consuming aspects of day-to-day operations. Concourse’s agents are purpose-built for finance, with full connectivity to a company’s existing financial systems, enabling teams to retrieve and analyze data through natural language and dramatically increase productivity. Concourse is backed by leading Silicon Valley investors including Standard Capital, Andreessen Horowitz, CRV, and Y Combinator.

Learn more at www.concourse.ai or connect with us via LinkedIn or X.

MEDIA CONTACT
[email protected]

SOURCE Concourse

New funding will scale a privacy-first platform that helps counselors adapt as admissions outcomes change year to year

NEW YORK, Jan. 27, 2026 — Nerd Apply, a privacy-first platform for outcome-driven college counseling, today announced it has raised $3.2 million in seed funding. The round included participation from Riverpark Ventures, Alumni Ventures, 1.61 Ventures and a group of highly notable angel investors including Gokul Rajaram and David Krane, CEO and Managing Partner of Google Ventures. The new capital will be used to scale distribution, deepen the company’s security, compliance, data governance infrastructure, and enable overall company growth.

Additional angel investors in the round include Will Griffith, Founder of ICONIQ Growth, Jeff Crowe, Managing Partner of Norwest Ventures and Chris Moore, Partner at Redpoint Ventures. The funding will also support continued product development to make the company’s qualitative admissions outcomes data more usable and actionable within counselor workflows and real-world advising conversations, alongside disciplined investments in go-to-market, customer success, and select engineering and product roles as the company scales.

“Students are making life-shaping decisions with incomplete or misleading information,” said Braden Weissman and Cooper Weissman, Co-Founders of Nerd Apply. “By aggregating real admissions outcomes from real students, we give counselors the clarity so they can guide students with confidence. This seed round allows us to scale responsibly while maintaining our standards for privacy, security, and trust.”

College admissions have grown increasingly complex, with students navigating rankings, anecdotes, and headlines while counselors are expected to provide confident, evidence-based guidance with limited reliable data. Nerd Apply addresses this gap by aggregating completed, fully de-identified admissions outcomes shared by counselors for counselors, enabling more realistic guidance without exposing student identities.

“I’m proud to be an investor in Nerd Apply, a company that is fundamentally shifting college counseling from guesswork to data-driven certainty,” said Gokul Rajaram. “By leveraging the world’s largest dataset of successful applications, they are empowering advisors with the objective insights needed to help every student find their best-fit path.”

As Nerd Apply grows, the company aims to become the trusted infrastructure for qualitative admissions outcomes data, helping counselors widen options, reduce uncertainty, and bring greater transparency to the college admissions process.

“Nerd Apply’s organic traction reflects a stellar team that is deeply committed to bringing clarity to an increasingly difficult to navigate college admissions process,” said Chris Moore. “The company sits at the intersection of data infrastructure, analytics, and trusted platforms – areas where their exceptional group of investors have spent decades operating. I’m excited to participate in one of the most influential rounds in education technology that is already delivering meaningful education outcomes at scale.”

ABOUT NERD APPLY
Nerd Apply helps students find their best-match schools by giving counselors a privacy-first data platform. Trusted by 500+ counselors and powered by over 100,000 real applications, Nerd Apply makes it easy to organize student information, understand admissions patterns, and share insights without exposing identities. Instead of chasing the same 80 ultra-selective colleges, counselors use Nerd Apply to widen options, set clear expectations, and reduce anxiety for families.

Media Contact:
Paul Bilardo
[email protected]

SOURCE Nerd Apply

AURORA, Colo., Jan. 27, 2026 — Navidence, a technology company focused on defining health data and supporting researchers in study design, today announced it has completed its Series Seed preferred funding round, co-led by Grand Ventures (Grand Rapids, Michigan) and Nina Capital (Barcelona, Spain).

The life sciences industry is increasingly embracing ethically obtained health data, or real-world data (RWD), but determining which RWD is appropriate for specific research use cases, such as clinical trials, remains hampered by tedious, manual processes that burden research teams.

Founded in 2022, Navidence offers AI-native technology and professional services that make it radically easier to design and deploy clinical research studies using RWD. The company’s platform develops Computable Operational Definitions (CODefs)—standardized, human and computer readable definitions of key study elements—creating a bridge between clinical healthcare and research while providing the consistency, precision, efficiency, and trust demanded by regulatory agencies.

“There’s an enormous opportunity to make real-world data more usable and trustworthy,” said Aaron Kamauu, CEO and co-founder of Navidence. “With this funding, we’re advancing tools that directly reduce burdens on research teams, making the work—from protocol creation to study execution—more efficient and quickly aligning stakeholders throughout the process.”

RWD plays an increasingly significant role in how therapies are developed, evaluated, and used, but researchers often struggle with fragmented and inconsistent definitions—the basic building blocks of data science. Navidence’s approach combines technology, curated CODef libraries, and expert services so teams can more confidently design studies, agnostically and objectively selecting fit-for-purpose RWD.

“As real-world data becomes increasingly central to drug development and regulatory decision-making, the industry needs more than access to data—it needs clarity, consistency, and trust in how that data is defined and used,” said James Hill, Partner at Grand Ventures. “Navidence is building foundational infrastructure that helps life sciences teams translate complex, fragmented healthcare data into standardized, computable definitions that can be reused and trusted across studies. Their combination of software and thought-leading domain expertise is deeply embedded in customer workflows, and we believe it positions Navidence to become core infrastructure for RWD-driven research.”

“At Nina Capital, we back companies that solve fundamental bottlenecks in healthcare through meaningful innovation,” said Sebastian Anastassiou, Partner and Head of Investments at Nina Capital. “Navidence is providing the essential ‘Rosetta Stone’ for real-world data, transforming disparate health information into standardized, computable evidence. By bridging the gap between clinical care and rigorous research, they aren’t just improving study design—they’re building the infrastructure necessary to make RWD-driven research a global standard.”

About Grand Ventures

Grand Ventures is an early-stage venture capital firm that invests in high-growth companies across sectors including digital health, Fintech, and DevOps. The firm partners with founding teams in the U.S. and beyond to help them scale category-defining technologies.

About Nina Capital

Nina Capital is a European venture capital firm based in Barcelona that invests in early-stage health technology companies at the intersection of data, computing, and life sciences. The firm backs founders around the world building technology-enabled solutions to address critical healthcare needs, deploying pre-seed and seed capital to fuel their growth.

About Navidence

Navidence is a technology company that helps healthcare and life sciences organizations design and assess the use of real-world data in clinical research studies and clinical trials. Through its platform and Computable Operational Definitions (CODefs), Navidence enables consistent, transparent, and reproducible analysis of complex real-world data to support smarter research and better patient outcomes.

For media inquiries, please contact:

Andrew Ecob
Chief Commercial Officer
Navidence, Inc.
+1 (833) 991- 0344
[email protected]
navidence.com

SOURCE Navidence, Inc.

Funding supports continued platform expansion and AI-powered diligence innovation as private markets become core to advisory portfolios

ATLANTA, Jan. 27, 2026 — Gridline, a turnkey alternatives management platform designed to help advisory firms build and manage private market investments, today announced it has raised $18.5 million in Series A funding led by FINTOP.

The funding will accelerate Gridline’s mission to replace fragmented systems and manual workflows with a single, integrated platform purpose-built to support private market investing with the scale, reliability, and operational rigor required in the wealth channel.

Private market investments have evolved from niche allocations to a core component of client portfolios. Yet many advisory firms continue to manage these investments across disconnected tools, spreadsheets, and service providers, creating operational risk, limited scale, and slowed adoption. In a 2025 CFA Institute Global Survey of investment professionals, transparency in valuation reporting and performance measurement ranked among the top concerns about private markets. With private market assets projected to reach $32 trillion by 2030, the need for scalable, purpose-built infrastructure is accelerating.

“There’s no shortage of tools in this space, but most solve only a narrow slice of the problem,” said Logan Henderson, co-founder and chief executive officer of Gridline. “We built Gridline as an end-to-end platform advisors can rely on to run private market programs with confidence and consistency. By owning the underlying data infrastructure, we keep information standardized, up-to-date, and actionable, so firms have accurate insights in one place, exactly when they need them. That foundation delivers the intelligence, control, and reliability advisors have been missing in private markets.”

Gridline provides advisory firms with a centralized platform that supports the full private markets operating lifecycle, replacing spreadsheets, PDFs, and disconnected portals with a single system for investment diligence, onboarding, execution, oversight, and reporting. This foundation helps firms reduce manual effort, mitigate operational risk, and scale private market offerings with institutional discipline.

“It’s surprising no one had fixed how painful it was to manage investor relationships and fund operations, especially with efficiency being so important to clients,” said Larry Cummings, partner at GENCapital Advisory Partners. “Gridline filled the gap everyone else danced around. Now I can focus on strategy and portfolio design, not chasing documents or cleaning up reporting.”

Based on customer feedback, advisory firms using Gridline report up to a 90% reduction in time spent on manual reconciliation, along with an estimated 10–30 hours saved per investment on diligence-related work and monitoring.

“Across wealth management and private banking, firms are constantly challenged to deliver best-in-class private market solutions at scale. Yet there had not been a platform purpose-built to facilitate these workflows with the control and consistency required until Gridline,” said Rick Kushel Managing Partner at FINTOP. “Gridline is solving a foundational problem for the 22 trillion dollar industry and we’re excited to support their next phase of growth.”

The new funding will support continued innovation across the Gridline platform, beginning with AltComply, the company’s AI-powered diligence capability. AltComply automates document ingestion, standardizes analysis, and surfaces key risks to help firms evaluate private investments more efficiently and consistently. The company will also expand its team across engineering, go-to-market, operations, and fund administration.

About Gridline
Gridline is a turnkey, end-to-end platform purpose-built for private market investing in the wealth channel. The company works with registered investment advisers (RIAs), multi-family offices, and private banks to help them manage and scale private market investment programs with institutional rigor. By rebuilding private markets infrastructure from the ground up on a ledger-native foundation, Gridline replaces fragmented tools and manual workflows with a single, integrated platform spanning diligence, execution, administration, and reporting. The result is greater consistency, transparency, and control, making it easier for advisory firms to scale alternatives as a core part of their business. For more information, visit gridline.co.

About FINTOP
FINTOP = Financial Technology Operating Partners. FINTOP backs the builders’ rewiring finance. With offices in Nashville & New York, the venture firm has $700 MM+ in committed capital across five funds and a team with decades of industry experience as entrepreneurs, operators, & investors. More via fintopcapital.com

Media Contact
AJ Traver-Williams
Head of Marketing, Gridline
[email protected]

SOURCE Gridline

Advanced biosynthesis company will accelerate commercialization of critical pharmaceutical ingredients and establish U.S. manufacturing operations

MENLO PARK, Calif., Jan. 27, 2026 — Antheia, the advanced biosynthesis company delivering 21st-century pharmaceutical manufacturing and innovation, today announced it has completed a second close of its Series C financing, raising an additional $24 million. Combined with additional available capital and non-dilutive funding, including multiple project agreements with the U.S. government, the company has secured more than $175 million over the past year.

Proceeds from the financing will be used to expand Antheia’s commercial manufacturing capacity, advance the company’s vast pipeline of late-stage biosynthetic pharmaceutical ingredients to market, and establish its U.S. manufacturing operations to support national onshoring priorities.

“Advanced biosynthesis has immense potential to transform pharmaceutical supply chains and unlock a new era of innovative medicines,” said Dr. Christina Smolke, CEO and co-founder of Antheia. “Building on the success of our Series C, this additional infusion of capital will fuel our efforts to address urgent supply chain vulnerabilities and more broadly, lead a paradigm shift for pharmaceutical manufacturing.”

The second close was led by ATHOS KG and America’s Frontier Fund, with participation from several existing investors, including Global Health Investment Corporation (GHIC), who co-led the initial Series C close with EDBI.

“America’s Frontier Fund invests in companies that strengthen U.S. industrial leadership and secure critical supply chains,” said Jeff Karras, General Partner at America’s Frontier Fund. “Antheia is redefining how essential medicines are made by combining advanced biosynthesis with scalable domestic manufacturing. This approach addresses longstanding shortages, long lead times, and geopolitical risk. We are excited to support Antheia as it builds a more resilient and secure U.S. pharmaceutical ecosystem.”

Today’s news follows several major milestones spanning 2024 and 2025, including Antheia’s first commercial delivery of thebaine — the key ingredient used to produce Narcan — and two U.S. government project agreements to onshore pharmaceutical supply chains. In November 2025, Antheia also announced a strategic partnership with TAPI to further commercialize its pipeline.

About Antheia
Antheia is the advanced biosynthesis company transforming pharmaceutical manufacturing and innovation for the 21st century. Antheia’s commercially proven technology platform produces high-value pharmaceutical ingredients in a fraction of the time compared to legacy approaches while significantly reducing supply chain risk. The company provides its global pharmaceutical customers with a resilient, efficient supply of critical ingredients at scale, while expanding the innovation frontier for new therapeutic development. Backed by leading investors and recognized by the U.S. government as a priority technology for public health and national and economic security, Antheia is manufacturing the medicines the world needs today while enabling tomorrow’s breakthrough therapeutics. For more information, visit www.antheia.bio.

MEDIA CONTACT:
Mission North for Antheia
[email protected]

SOURCE Antheia

SINGAPORE, Jan. 27, 2026 — EPG recently completed its Series B financing, raising nearly US$100 million. The round was co-led by international investment firms Forebright and Silicon Peak, with participation from GL Ventures, NRL Capital, YF Capital, and Rockets Capital. In 2025, EPG also completed its Series A and A+ rounds, raising tens of millions of U.S. dollars from investors including Eastern Bell VC, laying a solid foundation for its next phase of growth.

Founded in 2004 by a team with over two decades of industry experience, EPG is a modular data center solution provider specializing in factory-prefabricated integration of power, IT, and cooling systems. Proceeds from the Series B financing will support capacity expansion, working capital, and global growth, strengthening EPG’s ability to deliver large-scale, high-power-density AI data centers globally.

The global data center industry is facing growing efficiency challenges, particularly in overseas markets such as Southeast Asia and Europe, where weak local supply chains and shortages of skilled labor lead to long construction cycles and higher costs. At the same time, AI-driven workloads are increasing requirements for delivery speed, power density, and thermal efficiency, pushing traditional construction models to their limits.

Against this backdrop, EPG addresses these challenges through modular, factory-prefabricated data center solutions. Its MDC approach shifts the majority of construction activities to the factory, where modules are assembled and tested before rapid on-site installation and commissioning. Backed by manufacturing hubs in Johor Bahru and Shanghai, end-to-end global delivery teams, and in-house technologies such as cold-plate liquid cooling systems achieving PUE below 1.3 and self-developed diesel generator sets, EPG enables faster, more reliable, and cost-efficient data center deployment across international markets.

Alick Wan, Founder, Chairman and CEO of EPG, said: “This Series B financing reflects strong confidence from leading global investors. Looking ahead, we will continue to invest in R&D, manufacturing, and global delivery capabilities to support fast, reliable data center deployment for customers worldwide.”

For more information, visit www.epg-module.com or contact [email protected]. 

About EPG

EPG is a Singapore-headquartered provider of modular and prefabricated data center infrastructure, powered by dual R&D centers in Singapore and Shanghai and advanced manufacturing hubs in Malaysia and China. With over 20 years of engineering expertise, EPG delivers innovative and sustainable solutions for hyperscale, cloud, and enterprise deployments across APAC, EMEA, the Americas, and other global markets.

SOURCE EPG Singapore Pte Ltd

Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and more

LOS ANGELES and MELBOURNE, Australia, Jan. 26, 2026 — 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading “CT:VQ™” product and significantly boost research and development—bolstering 4D’s technology lead in software-based lung imaging.

CT:VQ™ is 4DMedical’s FDA-cleared, SaaS technology that provides ventilation and perfusion insights from CT imaging. Within just four months of FDA clearance, CT:VQ was deployed by four elite U.S. academic medical centers: Stanford, Cleveland Clinic, University of Miami, and UC San Diego Health. These rapid adoptions reflect growing interest from clinicians seeking quantified, actionable and functional information not available from traditional imaging–but increasingly vital to support diagnosis, treatment planning, and longitudinal monitoring.

“This is an extraordinarily important and validating event for multiple reasons,” says Andreas Fouras, PhD, 4DMedical Founder and CEO. “First, it reflects growing global recognition of the technological leadership of 4DMedical, including our groundbreaking products such as CT:VQ™. And it recognizes both the commercial progress and even greater growth potential we have in the U.S. With this strong institutional backing and a strengthened balance sheet, we will scale adoption, accelerate R&D, deepen partnerships, and dominate the global marketplace for software-based lung imaging tools.”

What the funding enables for hospitals and health systems

4DMedical will use the funding to expand U.S. availability of CT:VQ™ and support health systems with implementation at scale, including:

• Commercial expansion across U.S. academic medical centers and health systems, with a focus on real-world adoption and multidisciplinary use
• Customer success, training, and technical support to help integrate CT:VQ™ into existing clinical workflows and drive consistent utilization
• Ongoing research and development to expand 4DMedical’s technology leadership, product portfolio and capabilities in functional lung imaging
• Operational scale and flexibility to support additional growth opportunities and sustained clinical partnerships

Following the raise, 4DMedical reported a pro forma cash position exceeding US$130+ million (AU$200+ million), which will support the company’s U.S. expansion strategy and growing installed base.

Built to integrate into clinical workflows

4DMedical’s products are delivered through a Software-as-a-Service (SaaS) model designed to integrate with existing hospital infrastructure. The company also highlighted strategic partnerships, including with Philips, aimed at supporting broader adoption pathways.

Availability

Hospitals and imaging networks interested in evaluating CT:VQ™ can contact 4DMedical for implementation information, workflow considerations, and a demonstration.

About 4DMedical

4DMedical Limited (ASX:4DX) is a global medical technology company that creates and deploys the most advanced software-based cardiothoracic imaging technology—integrating both proprietary algorithms and artificial intelligence. 4DMedical’s software platform delivers deep, quantitative, insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease with significantly greater precision.

These insights help pulmonologists, radiologists and hospital teams quantify regional lung function, support diagnosis and disease monitoring, and inform treatment and surgical planning. 4DMedical’s solutions are designed to integrate into existing clinical workflows. They provide actionable, patient-specific information that supports better decision-making and operational efficiency across a range of respiratory conditions. Learn more at www.4dmedical.com.

SOURCE 4DMedical

Powerhouse Ventures leads investment in CVector’s novel AI solution for energy intensive industries.

NEW YORK, Jan. 26, 2026 — CVector announces an oversubscribed $5 million USD seed round led by Powerhouse Ventures, with participation by Fusion Fund, Hitachi Ventures, Myriad Venture Partners, and Schematic Ventures. CVector will use the funds to accelerate hiring in sales and product development and assist customers in scaling their current deployments.

Founded in November 2024 by industry veterans from Shell and CERN, CVector is already deployed across public utilities, advanced manufacturing, and chemical production. Its customers include ATEK Metals, known for operational excellence in complex metals processing as well as chemical companies like Ammobia, which is reinventing centuries old production processes.

“CVector’s AI native solution provides real time recommendations in the context of dynamic feedstocks, operating metrics, and customer demand,” says Richard Zhang, co-founder and CEO. “CVector sharpens decision-making around optimal production, ensuring every action is grounded in improved economics.”

Using high-resolution supply chain, control system, and market data, CVector generates prioritized recommendations based on economic models tailored to each facility’s operating parameters, evaluating every option by its impact on profitability.

“Contextualized industrial data may be the fuel for AI, but CVector is the only solution which addresses the additional issues of economic optimization and accessibility by end users,” says Emily Kirsch, Founder and Managing Partner of Powerhouse Ventures. “Addressing all three issues is required in the new generation of AI industrial software for improved decision making in production environments.”

CVector learns from operator behavior, tailoring recommendations based on how teams actually work. The result is faster root-cause analysis, smarter troubleshooting, and proactive system planning—all grounded in long-term historical trends and physical system understanding. These types of hybrid solutions augment human operators and engineers with AI-powered recommendations that are precisely targeted to drive measurable operational and economic improvements.

About CVector
CVector’s AI solution empowers industrial companies with real-time recommendations to optimize margins in the context of dynamic feedstock, energy, and finished product prices. Based on high resolution control systems and market data, these prioritized recommendations are built on economic models that account for the operating parameters of the facility, and analyze possible courses of action against their impact on profitability. CVector was founded in 2024 by industry veterans with expertise in AI and industrial software, and it is headquartered in New York City, USA.
For more information, visit www.cvector.com.

About Powerhouse Ventures
Powerhouse Ventures is a venture capital firm based in Oakland, California, investing in seed-stage startups that are building innovative software to rapidly decarbonize global energy and mobility systems. Founded in 2011, Powerhouse Ventures partners with entrepreneurs developing solutions for energy, mobility and industry.
For more information, visit https://powerhouse-ventures.co/.

About Fusion Fund
Founded in 2015, Fusion Fund is a Palo Alto–based venture capital firm that backs early-stage startups leveraging technical or data advantages. The firm partners with founders who have deep expertise in healthcare, enterprise AI, and industrial technology, helping them build the next generation of industry-defining companies. Fusion Fund invests in Pre-Seed, Seed, and Series A companies across the United States and Canada, with a focus on transformational businesses that address critical challenges in digitalization, efficiency, and scalability.
For more information, visit www.fusionfund.com.

About Hitachi Ventures
Hitachi Ventures is the global corporate venture capital arm of Hitachi, Ltd. With more than $1 billion in assets under management, Hitachi Ventures partners with ambitious founders to build world-changing innovations. The firm invests in four core themes driving the future of our planet: intelligent infrastructure, sustainable industry, life sciences, and digital ecosystems. By blending the global power of Hitachi with the speed of innovation, Hitachi Ventures acts as a force multiplier for startups transforming the world around us.
For more information, visit www.hitachi-ventures.com.

About Myriad Venture Partners
Myriad Venture Partners is an early-stage venture firm defining the future of business solutions. Investing in visionary AI, B2B software, and industrial transformation leaders, Myriad brings decades of expertise and a robust corporate and financial partnership network. By connecting entrepreneurs, corporate partners, industry leaders, and co-investors, Myriad is changing the ways businesses operate, compete, and create value. The firm is based in New York with portfolio companies across North America and Europe.
For more information, visit www.myriadventures.com.

About Schematic Ventures
Schematic Ventures is a venture capital firm focused on early-stage investments in supply chain, manufacturing, and industrial technologies. Schematic partners with technical founders building the next generation of operational infrastructure.
For more information, visit www.schematicventures.com.

Media Contact:
Richard Zhang
202-579-9478
[email protected]

SOURCE CVector